221 related articles for article (PubMed ID: 8901518)
1. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures.
Mazumder A; Neamati N; Ojwang JO; Sunder S; Rando RF; Pommier Y
Biochemistry; 1996 Oct; 35(43):13762-71. PubMed ID: 8901518
[TBL] [Abstract][Full Text] [Related]
2. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z
Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
[TBL] [Abstract][Full Text] [Related]
3. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
5. Ion selective folding of loop domains in a potent anti-HIV oligonucleotide.
Jing N; Rando RF; Pommier Y; Hogan ME
Biochemistry; 1997 Oct; 36(41):12498-505. PubMed ID: 9376354
[TBL] [Abstract][Full Text] [Related]
6. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
Mazumder A; Gazit A; Levitzki A; Nicklaus M; Yung J; Kohlhagen G; Pommier Y
Biochemistry; 1995 Nov; 34(46):15111-22. PubMed ID: 7578125
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex.
Mazumder A; Gupta M; Perrin DM; Sigman DS; Rabinovitz M; Pommier Y
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):115-25. PubMed ID: 7734185
[TBL] [Abstract][Full Text] [Related]
8. Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Implications for the role of lysine 136 in DNA binding.
Mazumder A; Neamati N; Pilon AA; Sunder S; Pommier Y
J Biol Chem; 1996 Nov; 271(44):27330-8. PubMed ID: 8910309
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
Pahl A; Flügel RM
J Biol Chem; 1995 Feb; 270(7):2957-66. PubMed ID: 7852375
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity of inhibition of HIV-1 integrase and virus replication by G-quartet oligonucleotides.
Jing N; Marchand C; Guan Y; Liu J; Pallansch L; Lackman-Smith C; De Clercq E; Pommier Y
DNA Cell Biol; 2001 Aug; 20(8):499-508. PubMed ID: 11560782
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.
Mazumder A; Cooney D; Agbaria R; Gupta M; Pommier Y
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5771-5. PubMed ID: 8016063
[TBL] [Abstract][Full Text] [Related]
12. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide.
Bishop JS; Guy-Caffey JK; Ojwang JO; Smith SR; Hogan ME; Cossum PA; Rando RF; Chaudhary N
J Biol Chem; 1996 Mar; 271(10):5698-703. PubMed ID: 8621435
[TBL] [Abstract][Full Text] [Related]
13. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action.
Mazumder A; Neamati N; Sunder S; Schulz J; Pertz H; Eich E; Pommier Y
J Med Chem; 1997 Sep; 40(19):3057-63. PubMed ID: 9301668
[TBL] [Abstract][Full Text] [Related]
14. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
[TBL] [Abstract][Full Text] [Related]
15. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
Neamati N; Hong H; Mazumder A; Wang S; Sunder S; Nicklaus MC; Milne GW; Proksa B; Pommier Y
J Med Chem; 1997 Mar; 40(6):942-51. PubMed ID: 9083483
[TBL] [Abstract][Full Text] [Related]
16. Zinc stimulates Mg2+-dependent 3'-processing activity of human immunodeficiency virus type 1 integrase in vitro.
Lee SP; Han MK
Biochemistry; 1996 Mar; 35(12):3837-44. PubMed ID: 8620007
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug.
Jing N; Hogan ME
J Biol Chem; 1998 Dec; 273(52):34992-9. PubMed ID: 9857031
[TBL] [Abstract][Full Text] [Related]
18. Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids.
Zhu K; Cordeiro ML; Atienza J; Robinson WE; Chow SA
J Virol; 1999 Apr; 73(4):3309-16. PubMed ID: 10074185
[TBL] [Abstract][Full Text] [Related]
19. Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase.
Yi J; Asante-Appiah E; Skalka AM
Biochemistry; 1999 Jun; 38(26):8458-68. PubMed ID: 10387092
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HIV-1 integrase activity by single-stranded oligonucleotides and their conjugates with eosin.
Korolev S; Knyazhanskaya E; Anisenko A; Tashlitskii V; Zatsepin TS; Gottikh M; Agapkina J
Nucleosides Nucleotides Nucleic Acids; 2011; 30(7-8):651-66. PubMed ID: 21888554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
